12:00 AM
 | 
Mar 23, 2009
 |  BC Week In Review  |  Company News  |  Deals

Inverness, Acon Laboratories Inc. deal

Inverness will acquire the remainder of Acon's rapid diagnostics business that it does not already own for about $200 million. The deal gives Inverness Acon's lateral flow immunoassay diagnostic products in China, Asia-Pacific, Latin America, South America, the Middle East, Africa, India, Pakistan, Russia and Eastern Europe....

Read the full 214 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >